Help

Powered by GGF
Home / NYT / Breakthrough Drug for Covid-19 May Be Risky for Mild Cases

Breakthrough Drug for Covid-19 May Be Risky for Mild Cases

-

By BY RONI CARYN RABIN from NYT Health https://ift.tt/3fUNEV9
via your-feed-science, Coronavirus (2019-nCoV), Dexamethasone (Drug), Clinical Trials, Immune System, Drugs (Pharmaceuticals), Steroids New York Times https://ift.tt/3fUNEV9 June 25, 2020 at 04:56AM
Breakthrough Drug for Covid-19 May Be Risky for Mild Cases Breakthrough Drug for Covid-19 May Be Risky for Mild Cases Reviewed by Imran Rk on June 24, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.